D842V PDGFRA doesn't bind sunitinib

Stable Identifier
R-HSA-9674398
Type
Reaction [transition]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

Sunitinib-resistant PDFGRA mutants include the D842V allele, occuring in the activation loop of the receptor, and the Y288C allele, which occurs in the extracellular domain and results in a version of the receptor that signals from intracellular compartments (Heinrich et al, 2008; Heinrich et al, 2012; Ip et al, 2019). Only the resistance of the D842V mutant is shown in this failed reaction.

Literature References
PubMed ID Title Journal Year
22665524 Sorafenib inhibits many kinase mutations associated with drug-resistant gastrointestinal stromal tumors

Heinrich, MC, Mariño-Enríquez, A, Presnell, A, Donsky, RS, Griffith, DJ, McKinley, A, Patterson, J, Taguchi, T, Liang, CW, Fletcher, JA

Mol. Cancer Ther. 2012
30389923 Neomorphic PDGFRA extracellular domain driver mutations are resistant to PDGFRA targeted therapies

Ip, CKM, Ng, PKS, Jeong, KJ, Shao, SH, Ju, Z, Leonard, PG, Hua, X, Vellano, CP, Woessner, R, Sahni, N, Scott, KL, Mills, GB

Nat Commun 2018
18955458 Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor

Heinrich, MC, Maki, RG, Corless, CL, Antonescu, CR, Harlow, A, Griffith, D, Town, A, McKinley, A, Ou, WB, Fletcher, JA, Fletcher, CD, Huang, X, Cohen, DP, Baum, CM, Demetri, GD

J. Clin. Oncol. 2008
Participants
Participant Of
Normal reaction
Disease
Name Identifier Synonyms
cancer 162 malignant tumor, malignant neoplasm, primary cancer
Authored
Reviewed
Created
Cite Us!